(415) 353-2421 (appt)

Box 0324, UCSF, San Francisco, CA 94143-0324

additional websites:

UCSF Physician Directory

Washington University; St. Louis, Missouri, A.B., 1968, Chemistry
University of Illinois Medical Center, Chicago, IL, M.D., 1972,
University of California, San Diego Intern, 1972-1973, Internal Medicine
University of California, San Diego Residency, 1973-1974, Internal Medicine
University of California, San Diego Residency, 1975-1976, Internal Medicine
Fred Hutchinson Cancer Research Center, Seattle, Washington, Fellowship, January-February, 1977, Bone Marrow Transplantation
University of California San Francisco, San Francisco, Fellowship, 1976-1979, Hematology/Oncology

Wolf, J.L., Mason, R.G. and Honig, G.R.: Regulation of hemoglobin β-chain synthesis in bone marrow erythroid cells by α-chains. Proc. Natl. Acad. Sci. 70:3406-3409, 1972.

Wolf, J., Fein, A. and Fehrenbacher, L.: Eosinophilic syndrome with methylphenidate abuse. Ann. Int. Med. 89:224-225, 1978.

Wolf, J., Perkins, H., Schreeder, M. and Vicente, F.: The transplanted kidney as a source of hepatitis infection. Ann. Int. Med. 91:412-413, 1979.

Blume, K., Beutler, E., Bross, K., Chillar, R., Ellington, O., Fahey, J., Farbstein, M., Schmidt, G., Scott, E., Spruce, W., Turner, M., and Wolf, J.: Bone marrow ablation and allogeneic marrow transplantation in acute leukemia: Clinical candidacy and outcome. N. Engl. J. Med. 302:1041-1046, 1980.

Wolf, J.L., McCutchan, J.A., Ziegler, E.J. and Braude, A.I.: Prophylactic antibody to core lipopolysaccharide in neutropenia. Proceedings of the 11th ICC and 19th ICAAC, American Society of Microbiology 1980. 1439-1441.

Wolf, J.L., Forman, S.J., Gaidulis, L. and Blume, K.G.: Angiotensin-converting enzyme in untreated Hodgkin�fs disease. Ann. Int. Med. 94:545-546, 1981.

Blume, K.G., Spruce, W.E., Forman, S.J., Wolf, J.L., Farbstein, M.J., Scott, E.P. and Fahey, J.L.: Bone marrow transplantation for acute leukemia. N. Engl. J. Med. 305:101-103, 1981.

Forman, S.J., Robinson, G.V., Wolf, J.L., Spruce, W.E. and Blume, K.G.: Lack of pulmonary problems with concomitant use of granulocyte transfusions and amphertericin-B. N. Engl. J. Med. 395:585, 1981.

Wolf, J.L., Spruce, W.E., Bearman, R.M., Forman, S.J., Scott, E.P., Fahey, J.L., Farbstein, M.J. and Blume, K.G.: Reversal of acute (malignant) myelo-sclerosis by allogeneic bone marrow transplantation. Blood 59:191, 1982.

Forman, S.J., Farbstein, M.J., Scott, E.P., Wolf, J.L., Spruce, W.E., Fahey, J.L., Nademanee, A. and Blume, K.G.: Prevention and therapy for graft-vs-host disease. N. Engl. J. Med. 307:376-377, 1982.

Blume, K.G., Spruce, W.E., Krance, R.A., Rosen, R. B., Forman, S.J., Farbstein, M.J., Wolf, J.L., Scott, E.P., Hecht, T. and Fahey, J.L.: Bone marrow transplantation for acute lymphoblastic leukemia. N. Engl. J. Med. 306:610, 1982.

Forman, S.J., Spruce, W.E., Farbstein, M.J., Wolf, J.L., Scott, E.P., Nademanee, A.P., Fahey, J.L., Hecht, T., Zaia, J.A., Krance, R.A., Findley, D.O. and Blume, K.G.: Bone marrow ablation followed by allogeneic marrow grafting during first complete remission of acute nonlymphocytic leukemia. Blood 61:439-442, 1983.

Scott, E.P., Forman, S.J., Spruce, W.E., Krance, R.A., Farbstein, M.J., Wolf, J.L., Nademanee, A.P., Fahey, J.L., Hecht, T. and Blume, K.G.: Bone marrow ablation followed by allogeneic bone marrow transplantation for patients with high risk acute lymphoblastic leukemia during completion remission. Transplantation Proceedings 15:1395-1396, 1983.

Rybicki, A.C., Heath, R., Wolf, J.L., Lubin, B. and Schwartz, R.S.: Deficiency of protein 4.2 in erythrocytes from a patient with a Coombs negative hemolytic anemia: Evidence of a role of protein 4.2 in stabilizing ankyrin on the membrane. Journal Clinical Investigation 81:893-901, 1988.

Linker, C.A., Ries, C.A., Damon, L.E., Rugo, H.S., Wolf, J.L.: Autologous bone marrow transplantation for acute myeloid leukemia using Busulfan plus Etoposide as a preparative regimen. Blood, 81:311-318, 1993.

Lienert-Weidenbach, K., Valiante, N.M., Brown, C., White, C., Johnston-Dow, L., McGinnis, M., Krausa, P., Lakes, D. M., Wolf, J. L., Blume, K.G., Parham, P.: Mismatches for two major and one minor histocompatibility antigen correlate with a patient's rejection of a bone marrow graft from a serologically HLA-identical sibling. Biology of Bone Marrow Transplantation 2(5):255-60, November 1997.

Linker, C. A., Ries, C.A., Damon, L.E., Rugo, H.S., Wolf, J.L.: Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report. Bone Marrow Transplantation 22, 865-872, 1998.

McGhee, E.M., Cohen, N.R., Wolf, J.L., Ledesma, C.T., and Cotter, P.D.: Monosomy 16 as the sole abnormality in myeloid malignancies. Cancer Genetics and Cytogenetics 118: 163-166, 2000.

Govberg, I.J., Wolf, J.L., and Cotter, P.D.: Trisomy 4 and double minutes in acute myeloid leukemia: Further evidence that double minutes can occur as the primary cytogenetic abnormality. Cancer Genetics and Cytogenetics 121:212-215, 2000.

Linker, C.A., Ries, C.A., Damon, L.E., Sayre, P., Navarro, W., Rugo, H.S., Rubin, A., Case, D., Crilley, P., Topolsky, D., Brodsky, I., Zamkoff, K., Wolf, J.L., Autologous Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission. Biology of Blood and Marrow Transplantation 6:50-57, 2000.

Damon, L.E., Wolf, J.L., Rugo, H.S., Gold, E., Zander, A.R., Cassidy, M., Cecchi, G., Cohen, N., Irwin, D., Tracy, M., Ries, C.A., Linker, C.A.: High-Dose Chemotherapy for Breast Cancer: Improved Results in Patients with >10 Involved Axillary Lymph Nodes. Bone Marrow Transplantation 26:3, 257 268, 2000

Damon, L.E., Wolf, J.L., Rugo, H.S., Gold, E., Zander, A.R., Cassidy, M., Cecchi, G., Cohen, N., Irwin, D., Tracy, M., Ries, C.A., Linker, C.A. High-Dose Chemotherapy (CTM) for Breast Cancer. Bone Marrow Transplantation 26:257-268, 2000.

Jagannath, S., Durie, B.G., Wolf, J., Camacho, E, Irwin, D., Lutzky, J., McKinley, M., Gabayan, E., Mazumder, A., Schenkein, D., Crowley, J. Bortezomib Therapy Alone and in Combination with Dexamethasone for Previously Untreated Symptomatic Multiple Myeloma. British Journal of Hematology 2005 June; 129(6):776-83.

7/8/08